Sarepta Therapeutics
SRPT
#1606
Rank
$10.58 B
Marketcap
$110.86
Share price
3.98%
Change (1 day)
33.47%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Revenue for Sarepta Therapeutics (SRPT)

Revenue in 2024 (TTM): $1.50 Billion USD

According to Sarepta Therapeutics 's latest financial reports the company's current revenue (TTM ) is $1.50 Billion USD. In 2023 the company made a revenue of $1.24 Billion USD an increase over the revenue in the year 2022 that were of $0.93 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sarepta Therapeutics from 1997 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $1.50 B21.04%
2023 $1.24 B33.26%
2022 $0.93 B32.93%
2021 $0.70 B29.96%
2020 $0.54 B41.82%
2019 $0.38 B26.51%
2018 $0.30 B94.74%
2017 $0.15 B2751.58%
2016 $5.42 M332.64%
2015 $1.25 M-87.16%
2014 $9.75 M-31.38%
2013 $14.21 M-61.91%
2012 $37.32 M-20.56%
2011 $46.99 M59.72%
2010 $29.42 M67.27%
2009 $17.58 M-17.26%
2008 $21.25 M93.52%
2007 $10.98 M9428.23%
2006 $0.11 M-97.59%
2005 $4.78 M1011.31%
2004 $0.43 M-55.62%
2003 $0.96 M15.9%
2002 $0.83 M18.51%
2001 $0.7 M-45.57%
2000 $1.29 M548.67%
1999 $0.2 M-50%
1998 $0.4 M33.33%
1997 $0.3 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$27.80 B 1,747.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.78 B-47.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.59 M-99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.38 B-74.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.09 B 39.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.90 B-40.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.34 B-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA